All In MedTech

Device Trial Radar · NCT07572331

Clinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 for the Treatment of Full-Face Wrinkles

NIRA™ Laser M2.1 and Topical Treatment of Full-Face Wrinkles: A CLINICAL TRIAL

Last checked: Nov 20, 2026Latest source record: May 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

120

Actual

Start

Jan 13, 2025

Primary completion

Oct 21, 2025

Study completion Oct 21, 2025

Sponsor

Lead sponsor
NIRA Innovations Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 7, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial evaluated the safety and effectiveness of the NIRA Laser M2.1, with or without a topical treatment, for the treatment of full-face wrinkles in adults. Participants were assigned to one of two treatment arms: laser-only treatment or laser treatment followed by topical treatment. Wrinkle improvement was assessed using standardized facial photographs reviewed by blinded evaluators, and participant satisfaction and safety observations were also assessed.

Conditions

  • Skin Ageing
  • Facial Wrinkles
  • Acne
  • Skin Elasticity
  • Infraorbital Dark Circle Severity
  • Skin Firmness
  • UV Spots
  • Skin Texture
  • Skin Pores
  • Brown Spots
  • Porphyrins
  • Red Spots

Interventions

  • NIRA Laser M2.1Device

    Hand-held OTC 1450nm diode laser device for full-face wrinkle treatment. Subjects treated themselves privately in their own homes, daily, per the Instructions for Use.

  • TopicalOther

    Topical skincare formulation designed for twice daily, full-face application. Used in Arm 2 only in addition to the NIRA Laser M2.1.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ARM 1 and ARM 2: Full Face Wrinkle Effectiveness Primary Endpoint a)Time frame: 28 weeks

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Northeast Dermatology Associates

    Beverly, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.